Category: CBSA News

NEWS RELEASE For Immediate Release: October 8, 2025 Enliven Therapeutics and Umoja Named Company of the Year FinalistsAmbrosia Biosciences, EnteroTrack, RheumaGen, and VitriVax Selected as Rising Star...

By: Fitzsimons Innovation Community As you know from all the buzz, this year marks a milestone for Fitzsimons Innovation Community—25 years since the opening of our first labs in Bioscience 1 in 2000....

As the federal government shuts down following the failure of Congress to agree on how to fund the government (with healthcare standing out as a flashpoint), and after the Trump Administration instruc...

This week’s policy blog includes federal and state updates on topics relevant to Colorado’s life sciences ecosystem:  Reauthorization of SBIR/STTR Programs  Colorado’s Budget Shortfall and S...

By: Elyse Blazevich Fitzsimons Innovation Community welcomed Elyse Blazevich as its guest blogger. As President & CEO of Colorado BioScience Association among many other roles, Elyse is at the for...

In recent weeks, CBSA’s Policy + Advocacy team has continued to strengthen our relationships with and showcase Colorado’s life sciences ecosystem to our state and federal legislators, legislative/cong...

For Immediate Release NEWS RELEASE Strategic, employer-led initiative supported by ZOMA Foundation, SyncUp Colorado, and Colorado Succeeds DENVER – Colorado BioScience Association and Colorado BioScie...

By: Fitzsimons Innovation Community From Military Heritage to Medical Innovation: City of Aurora Mayor Mike Coffman Reflects on the Fitzsimons Innovation Community Transformation As we continue our ce...

Two-Day Event Highlights the People, Partnerships, and Companies Propelling Colorado Toward a Top-Five National Ranking in Life Sciences DENVER — July 16, 2025 Colorado BioScience Association (CBSA) w...

On July 11, the Colorado Prescription Drug Affordability Board (PDAB or Board) held its second upper payment limit (UPL) rulemaking hearing for the autoimmune drug Enbrel, moving closer to becoming th...